Influencing Without Authority in Regulatory Affairs

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-27

Quick Answer

• Regulatory managers can influence submission timelines and quality standards by building expertise-based credibility with R&D, clinical, and commercial teams.
• Use structured communication tactics such as early alignment meetings, clear decision records, and escalation pathways to gain cooperation without formal authority.
• Influence without authority has limits, when safety or compliance risks escalate, formal escalation to senior leadership remains the required professional step.

Understanding the Regulatory Affairs Influence Problem

Regulatory affairs professionals occupy a unique position in life science organizations. They hold responsibility for submission quality, compliance, and market access, yet they rarely control the scientists, clinicians, and commercial staff whose work determines regulatory outcomes. This structural gap creates a persistent workplace challenge: how does a regulatory manager lead cross-functional teams toward submission readiness when those teams do not report to them?

The U.S. Bureau of Labor Statistics describes regulatory affairs as a field where professionals interpret and apply government regulations to ensure organizational compliance. The occupation sits at the intersection of science, law, and business, requiring both technical understanding and communication skill. Unlike line managers who can direct staff through reporting structures, regulatory professionals must achieve results through persuasion, evidence, and process design.

This article provides specific influence tactics and communication strategies tailored to regulatory contexts. The focus is practical: aligning R&D scientists on data requirements, coordinating clinical teams on submission timelines, and bringing commercial colleagues into compliance conversations before problems emerge.

The Structural Position of Regulatory Affairs

Where Regulatory Affairs Sits in Life Science Organizations

Regulatory affairs departments typically function as matrixed support functions. They serve multiple product teams, therapeutic areas, and development stages simultaneously. The department holds accountability for regulatory strategy, submission preparation, and ongoing compliance, but the people generating data, running trials, and planning launches report elsewhere.

This matrix structure means regulatory managers must accomplish work through people they do not supervise. The U.S. Department of Labor's O*NET OnLine database identifies coordination, negotiation, and persuasion as core skills for professionals who manage complex projects across organizational boundaries. Regulatory work exemplifies this pattern: every submission requires input from toxicology, pharmacology, clinical operations, biostatistics, manufacturing, and labeling teams.

Why Formal Authority Is Absent

Formal authority in organizations flows through reporting lines. A regulatory manager may hold a senior title, but that title does not grant the power to assign work to a clinical research associate or require a manufacturing scientist to repeat a stability study. The absence of formal authority is structural, not personal. It reflects the design of matrix organizations where functional expertise is distributed across departments.

The National Institutes of Health Office of Intramural Training and Education emphasizes that scientific careers increasingly require collaboration across disciplinary boundaries. Regulatory affairs exemplifies this trend. The regulatory professional must synthesize input from multiple specialties while maintaining accountability for the final submission package. This accountability without control defines the influence challenge.

Core Principles for Influencing Without Authority

Build Expertise-Based Credibility

The most durable source of influence for regulatory professionals is demonstrated expertise. When R&D scientists believe a regulatory manager understands the science, the data requirements, and the regulatory landscape, they are more likely to accept guidance. Expertise-based credibility develops through preparation, consistency, and demonstrated understanding of technical details.

Regulatory managers build credibility by mastering the specific regulatory requirements for their product area. This includes understanding which studies are needed, what endpoints matter, and how data should be presented. When a regulatory manager can explain why a particular assay validation approach will satisfy an agency expectation, scientists recognize that the guidance comes from knowledge, not bureaucracy.

The American Society for Microbiology career resources highlight that scientific professionals advance by developing both technical depth and communication capability. For regulatory professionals, this combination is essential. Technical depth earns respect from scientists, communication capability translates that respect into cooperative action.

Understand What Motivates Each Stakeholder Group

Different functional teams respond to different influence appeals. R&D scientists are motivated by scientific validity, publication opportunities, and the integrity of their research. Clinical teams are motivated by patient safety, trial efficiency, and clean data. Commercial teams are motivated by launch timelines, market positioning, and revenue projections.

Effective regulatory influence requires tailoring the appeal to the audience. A conversation about additional stability data with a manufacturing scientist should emphasize product quality and patient safety. The same conversation with a commercial colleague should emphasize launch timing and market access. The regulatory requirement is identical, but the framing differs based on what each stakeholder values.

The National Science Foundation careers pages describe federal research organizations where scientists and program staff must align on shared objectives despite different functional roles. The same principle applies in industry regulatory work. Influence succeeds when the regulatory manager connects compliance requirements to the stakeholder's own goals.

Establish Predictable Processes

Process design is a form of influence that operates without direct authority. When regulatory affairs creates clear, predictable processes for submission planning, data review, and timeline management, teams begin to rely on those processes. Reliance creates cooperation because the process makes everyone's work easier.

A well-designed regulatory process includes defined milestones, clear owners, and transparent status tracking. Teams know what to deliver, when to deliver it, and how their work fits into the larger submission. The process itself becomes the authority, reducing the need for the regulatory manager to personally direct each interaction.

The Association of American Veterinary Medical Colleges career resources note that structured approaches help professionals manage complex responsibilities across multiple stakeholders. Regulatory processes serve the same function in industry settings. They convert ambiguous expectations into concrete commitments that teams can plan around.

Communication Strategies for Regulatory Influence

Align on Submission Timelines Early

Timeline alignment is one of the most consequential influence opportunities for regulatory professionals. When submission timelines are set collaboratively at the start of a project, teams feel ownership of the schedule. When timelines are imposed later, teams resist and negotiate.

Effective timeline alignment begins with a planning meeting that includes representatives from each contributing function. The regulatory manager presents the submission requirements, the agency review timeline, and the internal milestones that must be met. Each functional representative identifies their contribution, the time required, and any dependencies on other teams. The group negotiates a realistic schedule that everyone commits to supporting.

This collaborative approach converts a regulatory mandate into a shared plan. The timeline becomes the team's timeline, not the regulatory department's timeline. When delays occur, the conversation shifts from blame to problem-solving because everyone has ownership of the schedule.

Use Decision Records to Create Accountability

Written decision records are a powerful influence tool because they create transparency and accountability. When regulatory decisions are documented with rationale, owners, and dates, teams cannot later claim they were unaware of requirements. The record becomes the reference point for future conversations.

A decision record should capture the decision, the regulatory basis, the people involved, and the agreed next steps. It should be distributed to all stakeholders and stored in a shared location. When questions arise later, the record provides the answer without requiring the regulatory manager to re-litigate the decision.

The National Institutes of Health training resources emphasize the importance of documentation in professional settings. Written records protect both the organization and the individuals involved by creating a clear account of what was agreed and why.

Frame Regulatory Requirements as Shared Constraints

Regulatory requirements are not optional preferences. They are binding constraints that apply to the entire organization. When regulatory managers frame requirements as shared constraints, they position themselves as allies helping teams navigate those constraints, not as obstacles imposing them.

This framing shifts the conversation from "the regulatory department wants this" to "the regulations require this, and we need to figure out how to meet the requirement together." The regulatory manager becomes a problem-solving partner instead of a gatekeeper. Teams are more willing to cooperate with someone who helps them find solutions within the constraints.

The U.S. Bureau of Labor Statistics describes regulatory affairs professionals as interpreters of regulations for their organizations. This interpretation role is inherently collaborative. The regulatory professional translates regulatory language into actionable requirements and helps teams understand what compliance means in practice.

Practical Workflow for Regulatory Influence

Step 1: Map the Stakeholder Landscape

Before attempting to influence anyone, the regulatory manager must understand who the stakeholders are and what they control. Create a stakeholder map that identifies each functional team involved in regulatory submissions, the specific individuals who make decisions, and the formal authority each person holds.

For each stakeholder, note their primary motivations, their past interactions with regulatory affairs, and their current workload. This map becomes the foundation for tailored influence strategies. It also reveals potential allies who can support regulatory positions in cross-functional meetings.

Step 2: Identify Influence Levers

Influence levers are the specific tools available to the regulatory manager. These include expertise, process design, data access, communication channels, and escalation pathways. Each lever works differently depending on the stakeholder and the situation.

Expertise works with scientists who respect technical knowledge. Process design works with teams who value efficiency and predictability. Data access works with stakeholders who need information to make decisions. Communication channels work with stakeholders who respond to direct engagement. Escalation works when other levers have failed and the issue warrants senior attention.

Step 3: Engage Early and Often

Influence is most effective when it happens before positions harden. Engage stakeholders early in project planning, not after problems emerge. Early engagement allows the regulatory manager to shape decisions while options are still open.

Regular communication maintains influence over time. Monthly check-ins, project updates, and informal conversations keep regulatory requirements visible and prevent surprises. The regulatory manager who communicates consistently is harder to ignore than one who appears only when problems arise.

Step 4: Document Agreements and Track Progress

Every significant agreement should be documented and tracked. Maintain a decision log that records what was agreed, who committed to what, and when deliverables are due. Share this log regularly with stakeholders so everyone sees the same picture.

Tracking progress serves two purposes. It creates accountability by making commitments visible. It also provides early warning of delays, allowing the regulatory manager to intervene before problems become critical.

Step 5: Escalate When Necessary

Escalation is a legitimate influence tool, but it should be used judiciously. Escalate when a compliance risk is material, when a stakeholder is refusing to engage, or when a timeline is at serious risk. Escalation should be framed as protecting the organization, not as punishing individuals.

The Association of American Veterinary Medical Colleges career guidance emphasizes that professionals should seek guidance from supervisors when facing challenges beyond their authority. The same principle applies in regulatory work. When influence fails and the risk is significant, the regulatory manager should escalate to senior leadership with a clear description of the issue and recommended actions.

At a Glance: Influence Tactics by Stakeholder Group

Records and Measurements for Influence Effectiveness

Track Influence Outcomes

Regulatory managers should track their influence effectiveness over time. Useful metrics include the percentage of submission milestones met on schedule, the number of late data deliveries from functional teams, and the frequency of rework due to misunderstood requirements. These metrics reveal whether influence strategies are working or need adjustment.

A simple tracking spreadsheet can capture each submission, the planned milestones, the actual completion dates, and any delays with reasons. Review this data quarterly to identify patterns. If the same team consistently misses deadlines, the influence approach with that team needs revision.

Document Escalation Patterns

Escalation patterns reveal where influence is failing. Track each escalation, the issue that prompted it, the stakeholder involved, and the outcome. If escalations cluster around a particular function or a particular type of issue, that pattern indicates a systemic problem requiring a different approach.

The National Science Foundation careers resources describe how program officers track project performance and intervene when issues arise. Regulatory managers can apply the same discipline to their cross-functional work. Systematic tracking converts anecdotal impressions into actionable data.

Measure Communication Effectiveness

Communication effectiveness is harder to measure but still worth tracking. Indicators include the number of clarifying questions after requirement documents are distributed, the frequency of rework due to misinterpretation, and stakeholder feedback from project retrospectives. These indicators reveal whether regulatory communications are clear and actionable.

When communication problems appear, revise the communication approach. Consider shorter documents, more visual presentations, or more frequent check-ins. The goal is to reduce the gap between what regulatory affairs intends and what stakeholders understand.

Common Failure Patterns in Regulatory Influence

The Compliance Gatekeeper Trap

Some regulatory managers fall into the trap of being seen only as a gatekeeper who says no. This pattern emerges when the regulatory professional focuses exclusively on requirements and rejections without offering solutions. Teams learn to avoid the regulatory department instead of engage with it.

The antidote is solution-oriented communication. When raising a requirement, also propose how to meet it. When identifying a gap, suggest how to close it. The regulatory manager becomes a partner in problem-solving instead of an obstacle to progress.

The Technical Lecture Failure

Regulatory managers with deep technical knowledge sometimes lecture stakeholders about regulations without connecting the requirements to the stakeholder's work. This approach alienates teams who feel talked down to instead of supported.

The antidote is audience-tailored communication. Explain the requirement in terms of what the stakeholder needs to do, not in terms of the regulatory framework. A manufacturing scientist needs to know what data to collect and why it matters for quality. A clinical coordinator needs to know what documentation to prepare and how it affects the trial timeline.

The Escalation Overuse Pattern

Escalation is a finite resource. When regulatory managers escalate every disagreement, senior leadership begins to discount their concerns. Escalation loses its power when it is used too frequently.

The antidote is strategic escalation. Reserve escalation for material compliance risks, significant timeline threats, or repeated non-cooperation. For minor issues, work through direct engagement and process design. The regulatory manager who escalates rarely but effectively commands more attention than one who escalates constantly.

The Documentation Gap

Some regulatory managers rely on verbal agreements and informal communication, leaving no record of what was agreed. When disagreements arise later, there is no reference point, and the regulatory manager must renegotiate from a weaker position.

The antidote is disciplined documentation. After every significant conversation, send a brief summary of what was agreed and what happens next. Maintain a decision log that all stakeholders can access. Documentation converts informal influence into durable agreements.

Options and Tradeoffs in Influence Approaches

Direct Engagement Versus Process Design

Direct engagement involves personal persuasion through meetings, conversations, and relationship building. Process design involves creating systems that make compliance easier and more predictable. Both approaches have value, but they trade off differently.

Direct engagement is flexible and responsive but depends on the regulatory manager's time and energy. Process design is scalable and durable but requires upfront investment and may feel impersonal. The most effective regulatory managers use both, engaging directly on high-stakes issues while building processes for routine compliance.

Collaboration Versus Enforcement

Collaborative approaches involve working with teams to find solutions within regulatory constraints. Enforcement approaches involve imposing requirements and escalating when they are not met. Collaboration builds goodwill and sustainable relationships. Enforcement produces compliance but can damage relationships.

The tradeoff depends on the situation. Collaboration works when stakeholders are willing to engage and when time allows for negotiation. Enforcement is necessary when compliance risks are material and when stakeholders refuse to cooperate. The skilled regulatory manager knows when to collaborate and when to enforce.

Early Engagement Versus Reactive Response

Early engagement involves raising regulatory considerations at project inception, before plans are locked. Reactive response involves addressing regulatory issues after they emerge. Early engagement is more effective but requires the regulatory manager to be involved in planning conversations that may not initially seem regulatory.

The tradeoff is between influence and efficiency. Early engagement consumes time on projects that may not proceed, but it prevents costly rework later. Reactive response is efficient in the short term but creates risk when regulatory issues surface late. The regulatory manager who invests in early engagement reduces the need for reactive intervention.

Welfare and Safety Context in Regulatory Influence

Patient Safety as the Foundation

The ultimate purpose of regulatory compliance is patient safety. Every submission, every data requirement, and every timeline exists to ensure that products are safe and effective before they reach patients. This safety mission is the strongest foundation for regulatory influence.

When regulatory managers frame requirements in terms of patient safety, they appeal to values shared across the organization. Scientists want their research to help patients. Clinical teams want their trials to protect participants. Commercial teams want to market products that are safe. The safety framing unifies these interests.

The U.S. Bureau of Labor Statistics describes regulatory affairs as ensuring that organizations comply with regulations designed to protect public health. This public health mission gives regulatory professionals moral authority that transcends organizational structure. The regulatory manager who leads with safety concerns is harder to dismiss than one who leads with procedural requirements.

Animal Welfare in Veterinary Regulatory Work

For regulatory professionals in veterinary medicine and animal health, animal welfare adds another dimension to the safety mission. The Association of American Veterinary Medical Colleges emphasizes that veterinary professionals are trained to consider animal welfare in all their work. Regulatory requirements in animal health exist to protect both animal patients and the humans who depend on them.

Influence conversations in veterinary regulatory contexts should acknowledge this welfare dimension. When asking a research team to repeat a study or add an endpoint, connect the requirement to animal welfare outcomes. Teams that care about animal welfare will respond to this framing.

Escalation for Safety Concerns

Safety concerns warrant escalation even when other influence approaches might eventually succeed. If a regulatory manager believes a product, study, or practice poses a safety risk, that concern should be raised immediately with senior leadership. Waiting to build consensus is not appropriate when safety is at stake.

The escalation should be documented, specific, and solution-oriented. Describe the safety concern, the evidence supporting it, and the recommended action. Senior leadership needs enough information to make a decision and to understand the consequences of inaction.

Professional Escalation Criteria

When to Escalate a Compliance Risk

Escalate when a compliance risk is material and cannot be resolved through direct engagement. Material risks include potential harm to patients, significant regulatory penalties, or substantial financial exposure. If the stakeholder refuses to address the risk, escalation is required.

The escalation should include a clear description of the risk, the evidence supporting the concern, the attempts already made to resolve it, and the recommended action. Senior leadership needs this information to make an informed decision.

When to Escalate a Timeline Threat

Escalate when a submission timeline is at serious risk and the delay cannot be absorbed. Timeline threats become material when they affect product launch dates, regulatory approval milestones, or contractual commitments. If the responsible team is unwilling or unable to meet the schedule, escalation is appropriate.

The escalation should quantify the impact of the delay and present options for recovery. Senior leadership can then decide whether to reallocate resources, adjust the timeline, or accept the risk.

When to Escalate Repeated Non-Cooperation

Escalate when a stakeholder repeatedly fails to cooperate despite reasonable influence efforts. Repeated non-cooperation is a pattern, not an isolated incident. It indicates that the influence approach is not working and that formal intervention is needed.

The escalation should document the pattern with specific examples, the influence attempts already made, and the impact of the non-cooperation. Senior leadership can then address the behavioral issue directly with the stakeholder's manager.

Frequently Asked Questions

How can a regulatory manager influence R&D scientists who resist regulatory requirements?

R&D scientists respond to technical credibility and scientific rationale. Prepare thoroughly by understanding the science behind the requirement, then explain how the regulatory expectation supports study quality and data integrity. Connect the requirement to the scientist's own goals of producing publishable, defensible research. The National Institutes of Health training resources emphasize that scientific professionals respect colleagues who demonstrate both knowledge and collaborative intent.

What should a regulatory manager do when a clinical team misses a submission deadline?

First, understand the reason for the miss. Clinical delays often stem from site recruitment issues, data cleaning problems, or protocol amendments. Work with the team to identify the root cause and develop a recovery plan. If the delay threatens the submission timeline, escalate to senior leadership with a quantified impact assessment and options for recovery.

Is escalation a sign of failure in regulatory influence?

Escalation is a legitimate professional tool, not a failure. It becomes a problem only when used excessively or for minor issues. The U.S. Bureau of Labor Statistics describes regulatory affairs as a field where professionals ensure compliance, and compliance sometimes requires formal intervention. Use escalation strategically for material risks and document the rationale.

How does regulatory influence differ in veterinary versus human health settings?

Veterinary regulatory work adds animal welfare considerations to the compliance mission. The Association of American Veterinary Medical Colleges emphasizes that veterinary professionals integrate animal welfare into their professional responsibilities. Influence conversations should acknowledge welfare outcomes alongside patient safety and market access. The core influence principles remain the same, but the framing should reflect veterinary values.

What records should a regulatory manager keep for influence effectiveness?

Maintain a decision log capturing agreements, owners, and dates. Track submission milestones against planned timelines and document delays with reasons. Record escalations with the issue, stakeholder, and outcome. Review these records quarterly to identify patterns and adjust influence strategies. The National Science Foundation careers resources describe similar tracking disciplines for program management.

How can a regulatory manager build credibility with commercial teams?

Commercial teams respond to market access framing. Explain how regulatory compliance enables launch timelines and protects market position. Connect regulatory requirements to revenue impact and competitive advantage. Avoid dismissing commercial concerns as irrelevant to regulatory work. The regulatory manager who understands commercial priorities can frame compliance as a business enabler.

What is the most common mistake regulatory managers make in cross-functional influence?

The most common mistake is relying on authority that does not exist. Regulatory managers who issue requirements and expect compliance without building relationships, explaining rationale, or offering solutions will face resistance. Effective influence requires preparation, communication, and partnership. The regulatory manager who invests in these skills achieves better outcomes than one who simply states requirements.

When should a regulatory manager escalate a safety concern immediately?

Escalate immediately when there is a credible risk of patient harm, animal welfare compromise, or significant regulatory penalty. Do not wait for consensus or attempt prolonged influence when safety is at stake. Document the concern, the evidence, and the recommended action, and raise it with senior leadership without delay. Safety concerns warrant escalation even when other influence approaches might eventually succeed.

Using the Evidence

Related Articles

• Cosmetics Regulatory Affairs Jobs: What You Need to Know
• Regulatory Affairs in Cosmetics: A Specialized Career Path
• Clinical Trial Manager: Skills, Responsibilities, and Career Path
• Biotech Regulatory Affairs Jobs: Roles, Skills, and Career Path
• Clinical Research Coordinator Interview Questions and How to Answer Them

References and Further Reading

• Occupational Outlook Handbook. U.S. Bureau of Labor Statistics.
• O*NET OnLine. U.S. Department of Labor.
• Office of Intramural Training and Education. National Institutes of Health.
• Careers at NSF. U.S. National Science Foundation.
• Career Services. American Society for Microbiology.
• AAVMC Career Resources. Association of American Veterinary Medical Colleges.
• NCBI Literature Resources. National Center for Biotechnology Information.
• PubMed. National Library of Medicine.

This article is educational and does not replace institutional policy, professional advice, or applicable safety and regulatory requirements.